These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32409893)

  • 21. Necrobiotic Xanthogranuloma.
    Portuguese AJ; Long TH; Linenberger M
    Mayo Clin Proc; 2021 Sep; 96(9):2432-2434. PubMed ID: 34481598
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
    Lee JW; Nam SB; Kim SJ
    Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic Performance of F-18 Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Differentiation of Benign and Malignant Vertebral Compression Fractures: A Meta-Analysis.
    Kim SJ; Lee JS
    World Neurosurg; 2020 May; 137():e626-e633. PubMed ID: 32105873
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Demaria L; Borie R; Benali K; Piekarski E; Goossens J; Palazzo E; Forien M; Dieudé P; Crestani B; Ottaviani S
    Clin Rheumatol; 2020 Sep; 39(9):2727-2734. PubMed ID: 32198555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a role for fluorine 18 fluorodeoxyglucose-positron emission tomography and positron emission tomography/computed tomography in evaluating patients with mycobacteriosis? A systematic review.
    Treglia G; Taralli S; Calcagni ML; Maggi F; Giordano A; Bonomo L
    J Comput Assist Tomogr; 2011; 35(3):387-93. PubMed ID: 21586936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis.
    Kim SJ; Pak K; Kim K
    Am J Otolaryngol; 2019; 40(2):297-305. PubMed ID: 30473166
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Obert J; Vercellino L; Van Der Gucht A; de Margerie-Mellon C; Bugnet E; Chevret S; Lorillon G; Tazi A
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):598-610. PubMed ID: 27645693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of CA125 and its kinetic parameters and positron emission tomography/computed tomography (PET/CT) with fluorodeoxyglucose ([
    Palomar Muñoz A; Cordero García JM; Talavera Rubio P; García Vicente AM; González García B; Bellón Guardia ME; Soriano Castrejón Á; Aranda Aguilar E
    Med Clin (Barc); 2018 Aug; 151(3):97-102. PubMed ID: 29276012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superiority of
    Jha A; Ling A; Millo C; Gupta G; Viana B; Lin FI; Herscovitch P; Adams KT; Taïeb D; Metwalli AR; Linehan WM; Brofferio A; Stratakis CA; Kebebew E; Lodish M; Civelek AC; Pacak K
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):787-797. PubMed ID: 29204718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.
    Mesguich C; Hulin C; Latrabe V; Lascaux A; Bordenave L; Hindié E; Marit G
    Ann Hematol; 2020 Dec; 99(12):2869-2880. PubMed ID: 32951093
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Chauvelot P; Skanjeti A; Jamilloux Y; de Parisot A; Broussolle C; Denis P; Ramackers JM; Giammarile F; Kodjikian L; Seve P
    Br J Ophthalmol; 2019 Nov; 103(11):1650-1655. PubMed ID: 30658987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rational use of
    Bisschop C; de Heer EC; Brouwers AH; Hospers GAP; Jalving M
    Crit Rev Oncol Hematol; 2020 Sep; 153():103044. PubMed ID: 32673997
    [No Abstract]   [Full Text] [Related]  

  • 33. DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile cancer.
    Jakobsen JK; Frahm Nielsen T; Ipsen P; Albrecht-Beste E; Cardoso Costa J; Alslev L; Predbjørn Krarup K; Grønkaer Toft B; Høyer S; Bouchelouche K; Bjerggaard Jensen J
    BJU Int; 2021 Feb; 127(2):254-262. PubMed ID: 33448605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The application of (18)F fluorodeoxyglucose-positron emission tomography/computed tomography in the diagnosis and treatment of dermatomyositis].
    Pei L; Guan ZW; Ji XJ; Wen QF; Sun F; Zhao Z; Jin JY; Zhu J; Zhang JL; Huang F
    Zhonghua Nei Ke Za Zhi; 2016 Jul; 55(7):525-30. PubMed ID: 27373287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDG PET/CT used in identifying adult-onset Still's disease in connective tissue diseases.
    Zhou X; Li Y; Wang Q
    Clin Rheumatol; 2020 Sep; 39(9):2735-2742. PubMed ID: 32180040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving the Diagnostic Performance of
    Swart LE; Gomes A; Scholtens AM; Sinha B; Tanis W; Lam MGEH; van der Vlugt MJ; Streukens SAF; Aarntzen EHJG; Bucerius J; van Assen S; Bleeker-Rovers CP; van Geel PP; Krestin GP; van Melle JP; Roos-Hesselink JW; Slart RHJA; Glaudemans AWJM; Budde RPJ
    Circulation; 2018 Oct; 138(14):1412-1427. PubMed ID: 30018167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
    Lee YJ; Kim YM; Jung PS; Lee JJ; Kim JK; Kim YT; Nam JH
    J Gynecol Oncol; 2018 May; 29(3):e36. PubMed ID: 29400023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
    Wu ZJ; Zhang YX; Wei H; Jia Q
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical impact of
    Jung JH; Lee SW; Son SH; Kim CY; Lee CH; Jeong JH; Jeong SY; Ahn BC; Lee J
    Head Neck; 2017 Mar; 39(3):447-455. PubMed ID: 27726225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.